分泌-话题@MedSci

#分泌#

651篇内容 | 2688人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1682688, encodeId=109316826887d, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, objectTitle=Nat Commun：临床试验证实，天然产物小檗碱调节胰岛素分泌，治疗糖尿病, objectType=article, longId=217675, objectId=94c121e675be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=94c121e675be, replyNumber=0, likeNumber=76, createdTime=2022-03-19, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=94c121e675be, moduleTitle=Nat Commun：临床试验证实，天然产物小檗碱调节胰岛素分泌，治疗糖尿病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=94c121e675be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1682683, encodeId=aa2416826834f, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, objectTitle=一文了解内分泌危象的表现及治疗, objectType=article, longId=216377, objectId=02e62163e721, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02e62163e721, replyNumber=0, likeNumber=70, createdTime=2022-07-06, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02e62163e721, moduleTitle=一文了解内分泌危象的表现及治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=02e62163e721)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1682638, encodeId=31d016826388c, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, objectTitle=Cell Metabolism：北大陈晓伟团队揭示高效特异调控血脂稳态的受体介导的脂蛋白分泌通路, objectType=article, longId=203390, objectId=271420339037, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=271420339037, replyNumber=0, likeNumber=62, createdTime=2020-12-31, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=271420339037, moduleTitle=Cell Metabolism：北大陈晓伟团队揭示高效特异调控血脂稳态的受体介导的脂蛋白分泌通路, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=271420339037)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1682680, encodeId=3989168268077, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, objectTitle=JCEM：内分泌干扰物与睾丸癌风险的关系, objectType=article, longId=214447, objectId=e8fc21444e00, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8fc21444e00, replyNumber=0, likeNumber=0, createdTime=2021-10-01, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8fc21444e00, moduleTitle=JCEM：内分泌干扰物与睾丸癌风险的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8fc21444e00)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1682656, encodeId=a3c816826566a, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, objectTitle=Cell stem report：星型胶质细胞分泌过量IL-6或是双向情感障碍治疗新靶点！ , objectType=article, longId=208194, objectId=35632081943d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=35632081943d, replyNumber=0, likeNumber=86, createdTime=2021-12-29, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=35632081943d, moduleTitle=Cell stem report：星型胶质细胞分泌过量IL-6或是双向情感障碍治疗新靶点！ , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=35632081943d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1682647, encodeId=74ba168264e12, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, objectTitle=Lancet oncol：S-1辅助治疗联合内分泌治疗用于ER+Her2-原发性侵袭性乳腺癌的疗效和安全性, objectType=article, longId=205423, objectId=1d0e20542306, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d0e20542306, replyNumber=0, likeNumber=85, createdTime=2021-04-10, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d0e20542306, moduleTitle=Lancet oncol：S-1辅助治疗联合内分泌治疗用于ER+Her2-原发性侵袭性乳腺癌的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d0e20542306)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1682664, encodeId=3e41168266486, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, objectTitle=津力达保护胰岛β细胞促进胰岛素分泌，改善糖代谢紊乱降低糖尿病微血管损伤, objectType=article, longId=210069, objectId=73482100695b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73482100695b, replyNumber=0, likeNumber=87, createdTime=2021-04-25, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73482100695b, moduleTitle=津力达保护胰岛β细胞促进胰岛素分泌，改善糖代谢紊乱降低糖尿病微血管损伤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73482100695b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1682641, encodeId=3eee16826416e, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, objectTitle=Clin Cancer Res：CEACAM5的调控及抗CEACAM5-SN38抗体-药物结合物在神经内分泌前列腺癌中的治疗效果 , objectType=article, longId=204057, objectId=4ed120405e9f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ed120405e9f, replyNumber=0, likeNumber=70, createdTime=2021-05-13, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ed120405e9f, moduleTitle=Clin Cancer Res：CEACAM5的调控及抗CEACAM5-SN38抗体-药物结合物在神经内分泌前列腺癌中的治疗效果 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ed120405e9f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1682648, encodeId=1ecc168264877, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, objectTitle=Lancet oncol：内分泌疗法加用帕博西尼是否可进一步改善早期乳腺癌患者预后？, objectType=article, longId=205838, objectId=7aaf20583880, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7aaf20583880, replyNumber=0, likeNumber=73, createdTime=2021-12-29, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7aaf20583880, moduleTitle=Lancet oncol：内分泌疗法加用帕博西尼是否可进一步改善早期乳腺癌患者预后？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7aaf20583880)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1682669, encodeId=7e891682669a5, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, objectTitle=The Oncologist：Palbociclib联合内分泌治疗HR+/HER2-转移性乳腺癌的安全性分析：来自PALOMA系列5年随访综合分析更新, objectType=article, longId=211389, objectId=ad602113894a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad602113894a, replyNumber=0, likeNumber=66, createdTime=2021-10-14, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad602113894a, moduleTitle=The Oncologist：Palbociclib联合内分泌治疗HR+/HER2-转移性乳腺癌的安全性分析：来自PALOMA系列5年随访综合分析更新, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad602113894a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1682668, encodeId=5f1d168266812, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, objectTitle=Aliment Pharmacol Ther：elobixibat通过影响分泌性胆汁酸来改善慢性便秘, objectType=article, longId=211217, objectId=e10121121e32, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e10121121e32, replyNumber=0, likeNumber=102, createdTime=2021-09-07, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e10121121e32, moduleTitle=Aliment Pharmacol Ther：elobixibat通过影响分泌性胆汁酸来改善慢性便秘, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e10121121e32)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1682665, encodeId=40d7168266508, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, objectTitle=Sci Rep：用于检测去势抵抗性前列腺癌患者治疗诱发的神经内分泌分化的新型非侵入性标志物 , objectType=article, longId=210647, objectId=bb1d21064eea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb1d21064eea, replyNumber=0, likeNumber=84, createdTime=2021-06-12, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb1d21064eea, moduleTitle=Sci Rep：用于检测去势抵抗性前列腺癌患者治疗诱发的神经内分泌分化的新型非侵入性标志物 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb1d21064eea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1682659, encodeId=31c616826598d, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, objectTitle=2021年美国内分泌年会速递：老药新用，利拉鲁肽，减肥新希望, objectType=article, longId=208847, objectId=921420884e69, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=921420884e69, replyNumber=0, likeNumber=76, createdTime=2021-09-30, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=921420884e69, moduleTitle=2021年美国内分泌年会速递：老药新用，利拉鲁肽，减肥新希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=921420884e69)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1682676, encodeId=b78316826e644, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, objectTitle=Cell：癌症的帮凶，新研究发现分泌型凝胶蛋白可抑制机体的癌症免疫力, objectType=article, longId=212853, objectId=2fd221285375, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fd221285375, replyNumber=0, likeNumber=70, createdTime=2022-02-18, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fd221285375, moduleTitle=Cell：癌症的帮凶，新研究发现分泌型凝胶蛋白可抑制机体的癌症免疫力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2fd221285375)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1682644, encodeId=949a16826447d, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, objectTitle=Chi-Med公司开始向美国FDA递交Surufatinib治疗晚期神经内分泌肿瘤的申请, objectType=article, longId=204981, objectId=5ad92049818f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ad92049818f, replyNumber=0, likeNumber=56, createdTime=2021-01-07, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ad92049818f, moduleTitle=Chi-Med公司开始向美国FDA递交Surufatinib治疗晚期神经内分泌肿瘤的申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ad92049818f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1682678, encodeId=319e16826e841, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, objectTitle=年轻乳腺癌ofs+AI后仍未绝经，后续如何进行内分泌治疗？, objectType=article, longId=213892, objectId=470a21389276, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=470a21389276, replyNumber=0, likeNumber=63, createdTime=2021-08-10, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=470a21389276, moduleTitle=年轻乳腺癌ofs+AI后仍未绝经，后续如何进行内分泌治疗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=470a21389276)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1682627, encodeId=cf7f168262eb7, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, objectTitle=TAG：二甲双胍在胰腺神经内分泌肿瘤患者治疗中的潜在作用, objectType=article, longId=200571, objectId=ff2d2005e105, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff2d2005e105, replyNumber=0, likeNumber=103, createdTime=2021-03-31, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff2d2005e105, moduleTitle=TAG：二甲双胍在胰腺神经内分泌肿瘤患者治疗中的潜在作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff2d2005e105)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1682651, encodeId=8c69168265187, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, objectTitle=子宫颈神经内分泌肿瘤诊疗, objectType=article, longId=206106, objectId=3478206106f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3478206106f6, replyNumber=0, likeNumber=93, createdTime=2021-09-24, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3478206106f6, moduleTitle=子宫颈神经内分泌肿瘤诊疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3478206106f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1682663, encodeId=5c6d16826638c, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, objectTitle=肿瘤病学年鉴：帕洛昔布联合内分泌治疗与卡培他滨治疗转移性乳腺癌的疗效比较, objectType=article, longId=209882, objectId=3ee42098821b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ee42098821b, replyNumber=0, likeNumber=63, createdTime=2021-04-27, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ee42098821b, moduleTitle=肿瘤病学年鉴：帕洛昔布联合内分泌治疗与卡培他滨治疗转移性乳腺癌的疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3ee42098821b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1682623, encodeId=932a16826236e, content=<a href='/topic/show?id=d4d031e8074' target=_blank style='color:#2F92EE;'>#分泌#</a>, objectTitle=【Nature子刊】肿瘤逃逸？阻止其分泌类固醇或可延缓肿瘤生长, objectType=article, longId=198772, objectId=38ef198e7210, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38ef198e7210, replyNumber=0, likeNumber=72, createdTime=2021-07-12, rootId=0, userName=一叶知秋, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38ef198e7210, moduleTitle=【Nature子刊】肿瘤逃逸？阻止其分泌类固醇或可延缓肿瘤生长, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=38ef198e7210)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

分泌

2020-05-29

一叶知秋 (审核中...)

前往app查看评论内容

#分泌#

Nat Commun：临床试验证实，天然产物小檗碱调节胰岛素分泌，治疗糖尿病

2022-03-19

一叶知秋 (审核中...)

前往app查看评论内容

#分泌#

一文了解内分泌危象的表现及治疗

2022-07-06

一叶知秋 (审核中...)

前往app查看评论内容

#分泌#

Cell Metabolism：北大陈晓伟团队揭示高效特异调控血脂稳态的受体介导的脂蛋白分泌通路

2020-12-31

一叶知秋 (审核中...)

前往app查看评论内容

#分泌#

JCEM：内分泌干扰物与睾丸癌风险的关系

2021-10-01

一叶知秋 (审核中...)

前往app查看评论内容

#分泌#

Cell stem report：星型胶质细胞分泌过量IL-6或是双向情感障碍治疗新靶点！

2021-12-29

一叶知秋 (审核中...)

前往app查看评论内容

#分泌#

Lancet oncol：S-1辅助治疗联合内分泌治疗用于ER+Her2-原发性侵袭性乳腺癌的疗效和安全性

2021-04-10

一叶知秋 (审核中...)

前往app查看评论内容

#分泌#

津力达保护胰岛β细胞促进胰岛素分泌，改善糖代谢紊乱降低糖尿病微血管损伤

2021-04-25

一叶知秋 (审核中...)

前往app查看评论内容

#分泌#

Clin Cancer Res：CEACAM5的调控及抗CEACAM5-SN38抗体-药物结合物在神经内分泌前列腺癌中的治疗效果

2021-05-13

一叶知秋 (审核中...)

前往app查看评论内容

#分泌#

Lancet oncol：内分泌疗法加用帕博西尼是否可进一步改善早期乳腺癌患者预后？

2021-12-29

一叶知秋 (审核中...)

前往app查看评论内容

#分泌#

The Oncologist：Palbociclib联合内分泌治疗HR+/HER2-转移性乳腺癌的安全性分析：来自PALOMA系列5年随访综合分析更新

2021-10-14

一叶知秋 (审核中...)

前往app查看评论内容

#分泌#

Aliment Pharmacol Ther：elobixibat通过影响分泌性胆汁酸来改善慢性便秘

2021-09-07

一叶知秋 (审核中...)

前往app查看评论内容

#分泌#

Sci Rep：用于检测去势抵抗性前列腺癌患者治疗诱发的神经内分泌分化的新型非侵入性标志物

2021-06-12

一叶知秋 (审核中...)

前往app查看评论内容

#分泌#

2021年美国内分泌年会速递：老药新用，利拉鲁肽，减肥新希望

2021-09-30

一叶知秋 (审核中...)

前往app查看评论内容

#分泌#

Cell：癌症的帮凶，新研究发现分泌型凝胶蛋白可抑制机体的癌症免疫力

2022-02-18

一叶知秋 (审核中...)

前往app查看评论内容

#分泌#

Chi-Med公司开始向美国FDA递交Surufatinib治疗晚期神经内分泌肿瘤的申请

2021-01-07

一叶知秋 (审核中...)

前往app查看评论内容

#分泌#

年轻乳腺癌ofs+AI后仍未绝经，后续如何进行内分泌治疗？

2021-08-10

一叶知秋 (审核中...)

前往app查看评论内容

#分泌#

TAG：二甲双胍在胰腺神经内分泌肿瘤患者治疗中的潜在作用

2021-03-31

一叶知秋 (审核中...)

前往app查看评论内容

#分泌#

子宫颈神经内分泌肿瘤诊疗

2021-09-24

一叶知秋 (审核中...)

前往app查看评论内容

#分泌#

肿瘤病学年鉴：帕洛昔布联合内分泌治疗与卡培他滨治疗转移性乳腺癌的疗效比较

2021-04-27

一叶知秋 (审核中...)

前往app查看评论内容

#分泌#

【Nature子刊】肿瘤逃逸？阻止其分泌类固醇或可延缓肿瘤生长

2021-07-12

科室
- - 订阅+
  - 更多科室
工具
服务